Israel Englander Humacyte, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q2 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Humacyte, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,552,947 shares of HUMA stock, worth $4.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,552,947

Previous 1,340,083 90.51%

Holding current value

$4.6 Million

Previous $2.29 Million 132.87%

% of portfolio

0.0%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.15 - $2.77 $1.39 Million - $3.36 Million	1,212,864 Added 90.51%	2,552,947 $5.34 Million
Q1 2025 May 15, 2025	BUY	$1.71 - $5.18 $720,301 - $2.18 Million	421,229 Added 45.84%	1,340,083 $2.29 Million
Q4 2024 Feb 14, 2025	SELL	$3.46 - $5.81 $1.21 Million - $2.03 Million	-348,653 Reduced 27.51%	918,854 $4.64 Million
Q3 2024 Nov 14, 2024	SELL	$5.11 - $9.46 $1.7 Million - $3.14 Million	-331,800 Reduced 20.75%	1,267,507 $6.9 Million
Q2 2024 Aug 14, 2024	BUY	$2.87 - $9.1 $3.83 Million - $12.1 Million	1,334,641 Added 504.27%	1,599,307 $7.68 Million
Q1 2024 May 15, 2024	SELL	$2.57 - $4.84 $2.65 Million - $4.99 Million	-1,030,700 Reduced 79.57%	264,666 $823,000
Q4 2023 Feb 14, 2024	BUY	$1.99 - $3.12 $2.58 Million - $4.04 Million	1,295,366 New	1,295,366 $3.68 Million
Q1 2023 May 15, 2023	BUY	$2.11 - $3.25 $58,816 - $90,593	27,875 New	27,875 $86,000
Q3 2022 Nov 14, 2022	BUY	$1.22 - $5.14 $30,640 - $129,091	25,115 Added 6.3%	423,880 $1.38 Million

Others Institutions Holding HUMA

# of Institutions

173

Shares Held

54.5M

Call Options Held

1.16M

Put Options Held

843K

View Full List

About Humacyte, Inc.

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $185M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

More about HUMA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account